Recent studies showed that human papillomavirus (HPV) integration contributes to the genomic instability seen in HPVassociated head and neck squamous cell carcinoma (HPV-HNSCC). However, the epigenetic alterations induced after HPV integration remains unclear. To identify the molecular details of HPV16 DNA integration and the ensuing patterns of methylation in HNSCC, we performed next-generation sequencing using a target-enrichment method for the effective identification of HPV16 integration breakpoints as well as the characterization of genomic sequences adjacent to HPV16 integration breakpoints with three HPV16-related HNSCC cell lines. The DNA methylation levels of the integrated HPV16 genome and that of the adjacent human genome were also analyzed by bisulfite pyrosequencing. We found various integration loci, including novel integration sites. Integration loci were located predominantly in the intergenic region, with a significant enrichment of the microhomologous sequences between the human and HPV16 genomes at the integration breakpoints. Furthermore, various levels of methylation within both the human genome and the integrated HPV genome at the integration breakpoints in each integrant were observed. Allele-specific methylation analysis suggested that the HPV16 integrants remained hypomethylated when the flanking host genome was hypomethylated. After integration into highly methylated human genome regions, however, the HPV16 DNA became methylated. In conclusion, we found novel integration sites and methylation patterns in HPV-HNSCC using our unique method. These findings may provide insights into understanding of viral integration mechanism and virus-associated carcinogenesis of HPV-HNSCC.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, accounting for 3-5% of all cancers. 1 Recently, the incidence of oropharyngeal cancer (OPC) has been reported to be increasing markedly. This is mainly because the number of human papillomavirus (HPV)-related oropharyngeal cancers (HPV-OPC) has risen globally, 2 while the incidence of HNSCC associated with the use of tobacco and alcohol use has remained constant or decreased.
The tumor biology and clinical characteristics of HPV-OPC differ from those of HPV-negative HNSCCs, which are mainly alcohol-and smoking-related HNSCCs. 3 Most patients with HPV-OPC present with advanced nodal stage, and tend to be younger than patients with non-HPVassociated tumors. Furthermore, HPV-OPC is associated with better response rates to treatment, and overall better prognosis when compared to non-HPV HNSCC. Therefore, the presence of HPV is now one of the most important prognostic factors in OPC patients. 2 While there are 15 high-risk subtypes of HPV with carcinogenic potential in humans, the vast majority of HPV-OPC is associated with HPV16. 4, 5 High-risk HPV infection of mucosal epithelia leads to the expression of viral E6 and E7 oncoproteins inducing the inactivation of both the p53 and the retinoblastoma (Rb) tumor suppressive proteins, which contribute to the malignant formation of HPV-related cancers. In addition, immune escape, genomic instability, HPV DNA integration and epigenetic alterations are also important for HPV-related cancer progression. 6 In fact, highrisk HPV integration is now known to be associated with the progression from low-to high-grade cervical intraepithelial neoplasia. 7 Many epigenetic alterations have also been reported during the process of cervical carcinogenesis in both the HPV and human genomes. 8 The mechanisms of these factors affecting HPV-induced cervical carcinogenesis have been thus well studied.
In HNSCC, a recent study using deep sequencing of HPV-HNSCC cell lines and HNSCC samples concluded that HPV16 integration itself directly promotes genomic instability and is important for carcinogenesis. 9 Park et al. have
shown that hypomethylation status within the viral genome, especially in the long control region (LCR) including E2 binding sites (E2BSs), was related to E6 and E7 expression in HPV-related HNSCC. 10 On the other hand, several articles have also reported that hypermethylation status in the ESBSs might cause deregulated E6 and E7 expression. 11, 12 Thus, the roles of altered methylation status of HPV during HPV-HNSCC development remain unclear. Therefore, the HPV methylation status, including the association of epigenetic alterations in HPV integrants and the flanking host genomes, requires further characterization to allow us a better understanding of the detailed mechanisms of the viral integration and carcinogenesis of HPV-HNSCC. In our study, we identified the molecular details of HPV16 DNA integration and the ensuing patterns of methylation in HPV-HNSCC with a previously reported 13 nextgeneration sequencing (NGS)-based method for methylation analysis of integrated viral genomes (G-NaVI) using 3 HPVrelated HNSCC cell lines to reveal the association of epigenetic alterations in HPV integrants and the flanking host genomes.
Materials and Methods

Cell lines
The UPCI:SCC090, UPCI:SCC152 and UPCI:SCC154 cell lines were kindly provided by Dr Susanne M. Gollin, University of Pittsburgh. The clinicopathological data for the patients and tumors from which the cell lines were derived are shown in Table 1 . Cell lines were maintained in appropriate media containing 10% fetal bovine serum in plastic culture plates. Adherent monolayer cultures were maintained on plastic and incubated at 378C in 5% CO 2 and 95% air. The integrity of each maintained cell line was clearly established by comparing the results from short tandem repeat profiling 14 with that reported for the original stock. 15 The cultures were free of Mycoplasma species and were maintained for no longer than 12 weeks after recovery from frozen stocks.
Analysis of HPV16 integration site sequences using nextgeneration sequencing (NGS)
Genomic DNA was extracted from cultured cells using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The concentration and quantity of extracted DNA were measured using a NanoDrop spectrophotometer (Nano Drop Technologies, Wilmington, DE). A total of 427 custom-made RNA probes covering the entire HPV16 DNA sequences were designed using the Agilent SureSelect Target Enrichment System, a highly efficient hybrid selection technique for optimizing NGS. After capture and amplification, the templates were sequenced using the GS FLX Titanium system (Roche, Basel, Switzerland). Reads that aligned perfectly with the human (GRCh37/hg19) or HPV16 (KO2718) genome were removed. Reads that aligned partially with the human genome and HPV16 genome were reserved. PCR and Sanger sequencing were used to verify the selected HPV integration breakpoints. PCR primers were designed to amplify the integrated HPV and the flanking human genome. As a template, 1 lL of genomic DNA solution was used in the subsequent PCR. Touchdown PCR was used for most of the assays. All PCR assays included a denaturation step at 958C for 30 s, followed by an annealing step at various temperatures for 30 s, and an extension step at 728C for 30 s. PCR products were analyzed using electrophoresis through 2% agarose gels.
Genomic elements around the integration positions
Genomic elements around the integration sites were analyzed using the RepeatMasker from the UCSC genome browser (https://genome.ucsc.edu/index.html). Each integration site was compared to previously reported integration and fragile sites. 16, 17 HPV16 breakpoints were mapped to the HPV16
What's new? Human papillomavirus (HPV) integration into the human genome induces genomic instability in HPV-associated squamous cell carcinoma; however, the details of the epigenetic alterations after HPV integration remain unclear. Here, the authors identified HPV16 integration breakpoints by next-generation sequencing using a target-enrichment method. Moreover, they observed that the methylation levels of the HPV16 integrants were associated with the methylation status of the flanking host genome using bisulfite pyrosequencing. The findings provide insights into the mechanisms for viral integration and carcinogenesis of HPV-associated head and neck squamous cell carcinoma and suggest that epigenetic alterations might provide candidate biochemical markers for precancerous stage.
genome, and the distribution of the integration sites was analyzed.
Microhomology (MH) calculation at the HPV16 genome integration sites
Bilateral sequences from the human and HPV16 genomes were extracted and the paired sequences were compared base by base to count the same sequences. The contiguous identical bases that could not be extended were defined as MH units and the MH lengths at the integration sites were also calculated.
DNA methylation analysis of the integrated HPV genome as well as the adjacent human genome DNA methylation was analyzed using bisulfite pyrosequencing. Bisulfite PCR was performed according to the manufacturer's protocol. One microliter of bisulfite-treated DNA, prepared using an EpiTect Bisulfite Kit (Qiagen), was used as a template. The primers used for amplifying the CpG sequences in the given sequence are described in Supplementary  Table 1 . After PCR, the biotinylated strand was captured on streptavidin-coated beads (Amersham Bioscience, Uppsala, Sweden) and incubated with sequencing primers (Supplementary Table 1 ). The pyrosequencing reactions were performed using the PyroMark Q24 Advanced (Qiagen) with the 3 HPV-HNSCC cell lines. Primers for the methylation analysis of integration sites in the UPCI:SCC090 line are shown in Supplementary Table 1. DNA fragments, including 150 bp of the integrated HPV DNA and 150 bp of the human genome around the boundary, were then analyzed for average methylation to examine the correlation between the methylation pattern of the integrated HPV DNA and that of the human genome.
Lastly, allele-specific DNA methylation of both the integrated HPV genome and adjacent human genome was analyzed as described previously. 18 For this analysis, the pyrosequencing reactions were performed using the PyroMark Q24 Advanced (Qiagen).
LINE1 methylation analysis
To quantify the relatively high LINE1 methylation levels, pyrosequencing technology was again used as described previously. 19 Briefly, PCR and the subsequent pyrosequencing for LINE1 were performed using the PyroMark kit (Qiagen).
This assay amplifies a region of the LINE1 elements that includes 3 CpG sites. PCR was conducted as follows: 45 cycles at 958C for 20 s, 508C for 20 s and 728C for 20 s, followed by 728C for 5 min. The biotinylated PCR product was purified and converted to single strands to serve as a template for the pyrosequencing reaction using the Pyrosequencing Vacuum Prep Tool (Qiagen). The pyrosequencing reactions were performed using the PyroMark Q24 (Qiagen). The percentage of Cs relative to the total sum of the Cs and Ts at each CpG site was calculated. The average of the percentages of Cs at the 3 CpG sites was used to represent the overall LINE1 methylation level in each cell line.
Statistical analysis
The Spearman correlation coefficient was used to assess correlations between the average methylation of the HPV DNA and that of the human genome. Randomly selected breakpoints across the human genome were used to compare the observed and expected integration results. The v 2 test was used for statistical analyses to compare variables between two groups. Statistical analyses were performed using GraphPad Prism Version 6.05 (GraphPad Software, La Jolla, CA) and IBM SPSS Statistics for Windows Version 22.0 (IBM Corp., Armonk, NY). A p-values of <0.05 was considered statistically significant.
Results
NGS analysis of HPV16 DNA integration site sequences
To detect the HPV16 integration sites effectively, we designed a target-enrichment technique using NGS analysis (Supplementary Fig. 1 ) with a total of 427 custom RNA probes to specifically target the HPV genome. The average read length was 414.18 bp, and the average read quality was 31.30 with >99.9% accuracy. The genome wide map of HPV16 integration sites is shown in (Fig. 1) . The HPV integrants were mapped to chromosomes 2q23, 3p12, 6p21 and 9q22 in UPCI:SCC090, chromosomes 2q23, 3p12, 9q22 and 9q31 in UPCI:SCC152, and chromosome 21q21 in UPCI:SCC154. Integration sites were mainly located in the intergenic regions, and no integration sites were observed in the promoter or exon region (Fig. 1 ). The UPCI:SCC090 and UPCI:SCC152 cell lines, derived from a recurrent tumor from the same patient, showed almost identical integration sites, although a lack of integration in chromosome 6 was observed in UPCI:SCC152. Our mapping of the HPV16 integration sites provided greater detail than a previous report using FISH and APOT-and DIPS-PCR analysis in UPCI:SCC090 and UPCI:SCC152 cells. 20 Furthermore, our results for the UPCI:SCC090 cell line was consistent with those of a previous report based on the whole genome sequence (WGS). 9 In addition, we found some new HPV integration sites in our study.
Characterization of genomic sequences adjacent to HPV16 integration breakpoints
To validate whether the HPV integrants in HNSCC target common fragile sites (CFSs) as reported previously in cervical cancers, 21 we compared the observed integration breakpoints in 3 cell lines with previously reported fragile sites. 16 We confirmed that these integration breakpoints are not only at or near CFSs but also at rare fragile sites (RFSs) in the UPCI:SCC090 and UPCI:SCC152 cell lines. Integration breakpoints in the UPCI:SCC154 cell line were detected at chromosome 21q21. This site was neither a CFS nor a RFS, however, it had previously been reported as one of the integration breakpoints in cervical cancer. 17 In addition, repetitive sequences at the integration sites were analyzed using RepeatMasker (http://www. repeatmasker.org/). Our results showed that 26/42 of the integration sites were distributed in repeating elements throughout the human genome. The number of integrations in long interspersed nuclear element (LINE) repeats (19/42) was found to be significantly larger than that of the expected occurrences by v 2 test (Fig. 2a, p 5 0.006). HPV16 integration sites were distributed across almost the whole genome except for E4. Breakpoints were prone to occur in E1 13/42 (Fig. 2b) , which is consistent with previous reports.
22,23
Distinct categories of viral-host sequence at the HPV16 integration breakpoints
Furthermore, viral-host junctional sequences were analyzed to reveal the existence of three distinct categories as reported previously. 24, 25 The first category was defined as a seamless transition from one sequence to the next with a clearly defined breakpoint, as shown in Figure 3a and 3d (4/42). The second category 15/42 was defined as the presence of short inserted sequences at the breakpoint that match neither reference sequence ( Fig. 3b and 3d , 15/42). The final category, which includes the majority of tumors 23/42, characterized by breakpoint microhomology was defined as the presence of several base of pairs of sequence homology at the breakpoint junction that could be assigned to either genome ( Fig. 3c and 3d , 23/ 42). In our samples, the breakpoint microhomology ranged from 1 to 7 bp in length. Furthermore, there was a significant enrichment of MHs when the MH length was 7 bp between the human genome and the HPV genome at or near integration breakpoints compared to the expected integration (p 5 0.002). When MH lengths were 3, 4 or 5 bp in length, the observed integrations tended to have more MHs than did the expected integrations; however, the differences were not significant (p 5 0.054, 0.17 and 0.21, respectively, Fig. 2c ).
Correlation between the methylation pattern of the integrated HPV16 DNA and the human genome DNA
To reveal the association between the epigenetic alterations in HPV integrants and the flanking host genomes, we first evaluated DNA methylation of the human genome at the HPV16 integration breakpoints by bisulfite pyrosequencing. We detected varying levels of methylation of the human genome at the HPV16 integration breakpoints in the genome of UPCI:SCC090, UPCI:SCC152 and UPCI:SCC154 cells as shown in Figure 4b and Supplementary Figure 2 . However, no association was observed between the presence of integration occurrence and methylation level of the human genome. We then evaluated DNA methylation of the integrated HPV16 genome by bisulfite pyrosequencing. We also found varying levels of methylation of the HPV16 sequences integrated into the genome of UPCI:SCC090, UPCI:SCC152 and UPCI:SCC154 cells. In addition, each integrant with the same viral gene showed differing methylation levels ( Fig. 4b and Supplementary Fig. 2 ). 
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To evaluate if the levels of methylation in the HPV16 DNA were associated with that of human genome, DNA fragments including the 150 bp of the HPV16 DNA and 150 bp of the human genome around the boundary were analyzed for average methylation. A statistically significant correlation was observed between the average methylation of the HPV16 and that of the human genome in all 3 cell lines (Figs. 5a and 5b) .
These results suggested that the DNA methylation status of the integrated HPV16 genome was affected by the methylation status of the human genome flanking integration breakpoints. As our previous report also showed that methylation of the integrated HBV DNA is related to the methylation status of the flanking human genome, 13 we therefore hypothesized that DNA methylation in the integrated HPV16 genome is related to the methylation status of the integration sites within the host genome.
Allele-specific DNA methylation analysis of the HPV16 genome
To confirm our hypothesis, we further characterized the methylation status of the HPV genome and human genome by allele-specific DNA methylation analysis (Fig. 4a) . We confirmed that the HPV genome was often highly methylated when integrated into highly methylated sites in the host genome, while the HPV16 genome remained largely unmethylated when integrated into unmethylated regions (Fig. 5c) . Our results thus suggested that the HPV16 integrants became hypomethylated when the flanking host genomes were hypomethylated.
LINE1 methylation analysis
Despite the fact that integration mainly occurs in intergenic regions, which are usually considered to be highly methylated, we found varying levels of methylation in the human genome at the HPV16 integration breakpoints. Therefore, we planned to evaluate the global methylation levels of these cell lines. As LINE1 methylation level has been reported to be a good indicator of the global DNA methylation level, [26] [27] [28] we performed LINE1 methylation analysis in these cell lines. We found hypomethylation status of LINE1 in all of 3 cell lines as shown in Figure 4c . These results indicate that global hypomethylation occurred in all 3 cell lines, consistent with the varying levels of methylation in intergenic regions observed in our study.
Discussion
In our study, we revealed the detailed association between the epigenetic alterations in HPV integrants and the flanking host genomes in 3 HPV-related HNSCC cell lines using our novel approach with an NGS-based method for the structural methylation analysis of integrated viral genomes. Our NGSbased method using unique probes enabled us to identify some previously unreported integrants and that the HPV genome is often highly methylated when integrated into highly methylated sites in the host genome, while HPV16 integrants remained hypomethylated when the flanking host genome was hypomethylated.
The methylation of viral DNA integrated into the human genome has been studied over the past decade 29 and in general it has been found that the local pattern of DNA methylation gradually spreads to involve the integrated viral genome. 30 Our study showed a statistically significant correlation between the average methylation level of the HPV16 DNA and that of the flanking host genome in 3 HPV-HNSCC cell lines. This correlation may be explained by our previous observation, indicating that the HBV genome often became significantly methylated when integrated into highly methylated host sites. 25 To the best of our knowledge, this is the first report to show a relationship between DNA methylation in the integrated HPV16 genome and the methylation status of the flanking host genome at the integration breakpoints in HPV-HNSCC. The methylation of viral DNA in the virus-integrated cells has the potential to alter the expression levels of the viral genome. 31 A previous report showed a causal relationship between the demethylation of gene bodies and altered expression of the associated genes in cancer. 32 Our current and previous results thus suggested that the HPV integrants might be inactivated by methylation when integrated into a highly methylated human genome, while the HPV integrants could remain unmethylated after integrated into an unmethylated host genome, leading to tumorigenesis. However, there remains possibility that some alterations of methylation status of the HPV genome are occurred before the HPV integration into the human genome, as several publications have reported the hypothesis indicating that differential methylation of the E2BSs is related to the activation of both viral oncogene expression and the viral genome remains in the episomal state. 12, 33 In this case, the methylation status of the 
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human genome might be affected by the methylation status of the HPV genome, as there were a couple of areas showing that the methylation status of human genome was not correlated with the methylation status of the HPV genome in our study. The biological impact of methylation on viral function needs to be further addressed. Since HPV integrations were mainly observed in non-coding regions in our study, the association of epigenetic alteration with non-coding RNAs, including miRNA and long non-coding RNA, might be related to these epigenetic alterations.
In addition, the hypomethylation of LINE1 was also observed in all 3 cell lines, indicating that global hypomethylation could occur in HPV-HNSCC. Global hypomethylation of DNA sequences is often observed, not only during the early stage of tumorigenesis or in abnormal non-neoplastic tissues, but also on tumor progression. 34 As the degree of DNA hypomethylation increases with the grade of cervical neoplasia, 35 the DNA hypomethylation status might serve as oropharyngeal precancerous marker, since HPV-induced precancerous lesions, such as cervical intraepithelial neoplasias, have yet to be noted. Recent genome-wide profiling of HPV integration in cervical cancer has shown that breakpoints could occur in any region of the viral genome, in contrast to the previously commonly held idea that integrated HPV16 would retain intact oncogene E6 and E7 with the long control region (LCR). 23 Our results in HPV-HNSCC cells were consistent with these previous results. In our study, the UPCI:SCC152 cell line, derived from a recurrent tumor in the patient from whom the UPCI:SCC090 cell line was derived, showed almost identical integration sites to UPCI:SCC090, which is consistent with a previous report that these cell lines have clonal expansion. 20 Interestingly, a lack of integration in chromosome 6
was observed only in the UPCI:SCC152 line. Further analysis would be required if this integration event itself caused genomic instability or the HPV integration tended to occur in the instable human genome regions.
There are several mechanisms for DNA repair, including non-homologous end joining (NHEJ), non-allelic homologous recombination (NAHR), fork stalling and template switching (FoSTeS), 36 and microhomology-mediated break-induced replication (MMBIR). 37 A recent report indicated that these mixed DNA-repair pathways participate in viral integration at genomic instability-related genomic elements. 23 The characteristics of the boundary including insertion and microhomology in our study were consistent with this idea. In addition, a previous report showed that microhomology occurred not only at the breakpoint but also near the breakpoint, which was called flanking microhomology. 24 This phenomenon was also reported in association with HPV genome integration in cervical carcinoma. 23 This mechanism was also observed in HBV integration, 23 indicating that both breakpoint and flanking microhomology might be a common mechanism for dsDNA virus integration. As several definitions exist for breakpoint and flanking microhomology, 23, 24 we only analyzed breakpoint microhomology in our study. Recently, Akagi et al. proposed a "looping model" to explain HPV integrant-mediated DNA replication and recombination leading to disruption of the expression and structure of neighboring genes. 9 Although our methodology was not able to examine the presence of this phenomenon, analysis around the boundary is thus important to understand molecular mechanism of HPV integration. One of the main limitations in our study was that only 3 cell lines were analyzed. A larger cohort, including clinical samples, should be analyzed to confirm our findings and to fully understand the pattern of methylation in the carcinogenesis of HPV-HNSCC. Other limitations might exist regarding the method itself using bisulfite pyrosequencing analysis with limited sequencing length from the boundary in our study. Particularly, the association between the methylation levels and transcription levels of the integrants in HPV-HNSCC cells could not be clarified in our study, since multiple HPV16 integration sites were present in the analyzed samples. We therefore have performed Amplification of Papillomavirus Oncogene Transcripts PCR (APOT-PCR) assay as described before 38 to detect both integrated and episomal state of HPV. This PCR-based assay showed that all of 3 cell lines had the integration pattern and two of 3 cell lines had the episomal pattern (data not shown). Thus, the observed association between the methylation of the HPV integrants and the flanking host genome probably needs to be clarified as sequencing technology advances in the future. Lastly, while our results for the UPCI:SCC090 cell line were consistent with those of a previous report using WGS 9 with some additional integration sites identified, there were also several integration sites identified by Akagi et al. 9 which we could not observe in our study. These small discrepancies could also be clarified with further advances in RNA sequencing technology. Despite these limitations, our results suggested that our G-NaVI method was a robust tool for the analysis of not only genomic sequences but also epigenetic alterations around integration breakpoints.
In conclusion, we here presented the molecular details of HPV16 DNA integration and various patterns of methylation in HPV-HNSCC using G-NaVI with 3 HPV-related HNSCC cell lines to reveal the association between epigenetic alterations in HPV integrants and the flanking host genomes. These results provided insights into the understanding of HPV integration in HNSCC with regard to HPV-related tumor progression, and also suggested that epigenetic alterations might provide candidate biochemical markers for establishing the precancerous stage in head and neck neoplasms. Together with previous reports on the whole genome and deep sequencing analysis, 9, 22 the detailed analysis performed in our study can help us understand the mechanisms for the viral integration and carcinogenesis of HPV-HNSCC.
